Natus Medical Incorporated
Vimab Group AB (publ), together with its subsidiaries, operates in the energy service, and industrial and environmental technology industries in Sweden and internationally. The company sells energy storage systems and fittings, as well as valve or spare part; and manufactures various products, such as portable valve grinding equipment, electric steam boilers, customized steam systems, molds, tool… Read more
Natus Medical Incorporated (NM4) - Total Assets
Latest total assets as of September 2025: €249.32 Million EUR
Based on the latest financial reports, Natus Medical Incorporated (NM4) holds total assets worth €249.32 Million EUR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Natus Medical Incorporated - Total Assets Trend (2014–2024)
This chart illustrates how Natus Medical Incorporated’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Natus Medical Incorporated - Asset Composition Analysis
Current Asset Composition (December 2024)
Natus Medical Incorporated's total assets of €249.32 Million consist of 44.7% current assets and 55.3% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 4.6% |
| Accounts Receivable | €23.76 Million | 9.0% |
| Inventory | €41.37 Million | 15.7% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €26.84 Million | 10.2% |
| Goodwill | €58.86 Million | 22.3% |
Asset Composition Trend (2014–2024)
This chart illustrates how Natus Medical Incorporated's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Natus Medical Incorporated's current assets represent 44.7% of total assets in 2024, a decrease from 50.1% in 2014.
- Cash Position: Cash and equivalents constituted 4.6% of total assets in 2024, down from 15.3% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 32.0% of total assets, a decrease from 43.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 22.3% of total assets.
Natus Medical Incorporated Competitors by Total Assets
Key competitors of Natus Medical Incorporated based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Legends Business Grp
PINK:LGBS
|
USA | $8.22 Million |
|
Grg Metrology
SHE:002967
|
China | CN¥6.56 Billion |
|
Orbitech Co. Ltd
KQ:046120
|
Korea | ₩126.48 Billion |
|
Kukbo Design Co. Ltd
KQ:066620
|
Korea | ₩507.35 Billion |
|
Centre Testing Intl Shenzhen
SHE:300012
|
China | CN¥9.86 Billion |
|
Shanghai HYP-ARCH Architectural Design Consultant Co.Ltd.
SHE:301024
|
China | CN¥703.68 Million |
|
Palgon AG
DU:3D6
|
Germany | €169.74K |
|
Rejlerkoncernen AB
F:3RE
|
Germany | €3.97 Billion |
Natus Medical Incorporated - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Natus Medical Incorporated generates 1.23x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Natus Medical Incorporated is currently not profitable relative to its asset base.
Natus Medical Incorporated - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.49 | 0.79 | 2.02 |
| Quick Ratio | 0.25 | 0.44 | 1.41 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-124.36 Million | € -36.26 Million | € 134.51 Million |
Natus Medical Incorporated - Advanced Valuation Insights
This section examines the relationship between Natus Medical Incorporated's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.78 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -22.2% |
| Total Assets | €263.55 Million |
| Market Capitalization | $1.95 Million USD |
Valuation Analysis
Below Book Valuation: The market values Natus Medical Incorporated's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Natus Medical Incorporated's assets decreased by 22.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Natus Medical Incorporated (2014–2024)
The table below shows the annual total assets of Natus Medical Incorporated from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €263.55 Million | -22.19% |
| 2023-12-31 | €338.71 Million | +72.59% |
| 2022-12-31 | €196.25 Million | -65.22% |
| 2021-12-31 | €564.29 Million | -6.01% |
| 2020-12-31 | €600.39 Million | -3.56% |
| 2019-12-31 | €622.53 Million | -2.45% |
| 2018-12-31 | €638.14 Million | -10.11% |
| 2017-12-31 | €709.92 Million | +9.38% |
| 2016-12-31 | €649.01 Million | +35.35% |
| 2015-12-31 | €479.50 Million | +10.27% |
| 2014-12-31 | €434.82 Million | -- |